Research graph
References from Acceptability and feasibility of fitness watches to monitor sleep and physical activity among women living with HIV: broadening the approach to optimizing cardiovascular health. Local targets link to admitted publications; unresolved targets remain external evidence.
HIV Infection and cardiovascular disease in women
10.1161/jaha.114.001035 · 2014 · External reference
Cardiovascular disease risk in women living with HIV
10.1097/coh.0000000000000756 · 2022 · External reference
Stroke incidence is highest in women and non-hispanic blacks living with HIV in the AIDS clinical trials group longitudinal linked randomized trials cohort
10.1097/qad.0000000000001799 · 2018 · External reference
Sex differences in the risk of stroke associated with traditional and non-traditional factors in a US cohort of people with HIV infection
10.1212/wnl.0000000000209726 · 2024 · External reference
Variation in heart failure risk by HIV severity and sex in people with HIV infection
10.1097/qai.0000000000003032 · 2022 · External reference
Cardiovascular disease in women living with HIV: a narrative review
10.1016/j.maturitas.2017.11.012 · 2018 · External reference
Cardiovascular disease risk among women living with HIV in North America and Europe
10.1097/coh.0000000000000413 · 2017 · External reference
Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: impact of gender and immune status
10.1371/journal.pone.0210253 · 2019 · External reference
Cardiovascular disease projections in the United States based on the 2020 census estimates
10.1016/j.jacc.2022.05.033 · 2022 · External reference
Cardiovascular risk of smoking and benefits of smoking cessation
10.21037/jtd.2020.02.47 · 2020 · External reference
Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention
10.1001/jamanetworkopen.2021.14923 · 2021 · External reference
Cardiovascular disease among persons living with HIV: new insights into pathogenesis and clinical manifestations in a global context
10.1161/circulationaha.122.057443 · 2023 · External reference
Cardiovascular risk estimation is suboptimal in people with HIV
10.1161/jaha.123.029228 · 2024 · External reference
HIV, inflammation, and immunometabolism: a model of the inflammatory theory of disease
10.3390/v17060839 · 2025 · External reference
HIV And cardiovascular disease: defining the unmeasured risk
10.1016/s2352-3018(18)30061-4 · 2018 · External reference
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVE
10.1016/s2352-3018(24)00276-5 · 2025 · External reference
Performance of cardiovascular risk prediction models among people living with HIV: a systematic review and meta-analysis
10.1001/jamacardio.2022.4873 · 2023 · External reference
Cardiovascular hazards of abacavir- versus tenofovir-containing antiretroviral therapies: insights from an analysis of the REPRIEVE trial cohort
10.1093/ofid/ofaf177 · 2025 · External reference
Unresolved reference
2024 · External reference
Effect of darunavir on lipid profile in HIV-infected patients
10.1310/hct1305-256 · 2012 · External reference
The risk of new heart failure associated with protease inhibitor: systematic scoping review
10.1177/09564624231196599 · 2023 · External reference
Weight gain and integrase inhibitors
10.1097/qco.0000000000000616 · 2020 · External reference
Association between weight gain and the incidence of cardiometabolic conditions among people living with HIV-1 at high risk of weight gain initiated on antiretroviral therapy
10.1007/s40121-022-00673-1 · 2022 · External reference
The association between weight gain, sex, and immune activation following the initiation of antiretroviral therapy
10.1093/infdis/jiab210 · 2021 · External reference
Early menopause in acquired immunodeficiency syndrome
10.4103/jrms.jrms_691_19 · 2021 · External reference
Menopause and women’s cardiovascular health: is it really an obvious relationship?
10.5114/aoms/157308 · 2023 · External reference
Menopause transition and cardiovascular disease risk
10.1016/j.maturitas.2024.107974 · 2024 · External reference
Cardiovascular risk in perimenopausal women
10.2174/1570161116666181002145340 · 2019 · External reference
Pitavastatin to prevent cardiovascular disease in HIV infection
10.1056/nejmoa2304146 · 2023 · External reference
Trial update of pitavastatin to prevent cardiovascular events in HIV infection
10.1056/nejmc2400870 · 2024 · External reference
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond
10.1161/circulationaha.109.192703 · 2010 · External reference
Life’s essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association
10.1161/cir.0000000000001078 · 2022 · External reference
Changing user experience of wearable activity monitors over 7 years: repeat cross-sectional survey study
10.2196/56251 · 2025 · External reference
Effectiveness of wearable trackers on physical activity in healthy adults: systematic review and meta-analysis of randomized controlled trials
10.2196/15576 · 2020 · External reference
Effect of wearables on sleep in healthy individuals: a randomized crossover trial and validation study
10.5664/jcsm.8356 · 2020 · External reference
Sleep quality by reproductive stage among women living with HIV in the United States enrolled in the health outcomes around pregnancy and exposure to HIV/antiretrovirals (HOPE) study
10.1097/qai.0000000000003856 · 2026 · External reference
Health outcomes around pregnancy and exposure to HIV/antiretrovirals (HOPE) study protocol: a prospective observational cohort study of reproductive-aged women living with HIV
10.1136/bmjopen-2024-084835 · 2024 · External reference
Statistical methods for assessing agreement between two methods of clinical measurement
10.1016/s0140-6736(86)90837-8 · 1986 · External reference
Validation of a consumer sleep wearable device with actigraphy and polysomnography in adolescents across sleep opportunity manipulations
10.5664/jcsm.7932 · 2019 · External reference
Fitbit physical activity and sleep data in the all of US research program. Data exploration and processing considerations for research
10.1249/mss.0000000000003804 · 2025 · External reference
Using a consumer wearable activity monitoring device to study physical activity and sleep among adolescents in project viva: cohort study
10.2196/59159 · 2025 · External reference
Unresolved reference
External reference
Sleep duration and health in adults: an overview of systematic reviews
10.1139/apnm-2020-0034 · 2020 · External reference
A systematic and meta-analytic review of the impact of sleep restriction on memory formation
10.1016/j.neubiorev.2024.105929 · 2024 · External reference
Tissue regeneration: impact of sleep on stem cell regenerative capacity
10.1016/j.lfs.2018.10.057 · 2018 · External reference
Sleep and immune function
10.1007/s00424-011-1044-0 · 2012 · External reference
Reliability and validity of commercially available wearable devices for measuring steps, energy expenditure, and heart rate: systematic review
10.2196/18694 · 2020 · External reference
Systematic review of the validity and reliability of consumer-wearable activity trackers
10.1186/s12966-015-0314-1 · 2015 · External reference
Acceptability and feasibility of using a fitness watch to monitor sleep and physical activity among women living with HIV
2025 · External reference
